FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
12/08/2026
Voltar para busca
Dado oficial do USPTO
STANDING TOGETHER WITH PATIENTS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
28
Atualização mais recente
12/08/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5, 44
Data de depósito
08/10/2024
Data de registro
12/05/2026
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
12/05/2026
Última transação
12/08/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
03
Localização do titular
JP
Examinador
OSBORNE, AUDRIANA R
Unidade examinadora
L60
Localização atual
FILE REPOSITORY (FRANCONIA)
Descrição da marca
The mark consists of the navy wording "STANDING" to the left of the blue stylized wording "TOGETHER" above the navy wording "WITH PATIENTS", above a purple and white styled image of two humans shaking hands forming from the blue "G" in "TOGETHER".
Titulares e representantes
Titulares
ONO PHARMACEUTICAL CO., LTD.
Representantes
Leigh Ann Lindquist SUGHRUE MION, PLLC
Classificação técnica
Classes Nice
Classe 5Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical preparations for the treatment and prevention of cardiovascular disordersgenitourinary disordersgynecological diseases and obstetric diseasescancer and its metastasiseye disordersneurologic disorderspsychiatric disordersendocrine and metabolic disordersallergic disordersgastrointestinal disordersimmune diseases and autoimmune diseasesrespiratory diseasesmusculoskeletal and connective tissue disordersinfectious diseasesdermatologic disordershematological disorderinflammatory diseasesearnosedental and throat disordershepatic and biliary disordersAlzheimer's diseasediabetes and its complications; glucose dietary supplements; lecithin dietary supplements; nutritional supplements; dietary supplements mainly consisting of seafood extracts in the form of powderspillscapsulesgranulesjellies or liquids; dietary supplements for human beings; dietary fiber to aid digestion; lyophilised food adapted for medical purposes; lyophilized meat adapted for medical purposes; dietetic beverages adapted for medical purposes; dietetic foods adapted for medical purposes; beverages for babies; food for babies
Classe 44
Provision of medical and pharmaceutical information via the Internet; provision of medical information relating to benefitsside effectsinteractions of pharmaceuticals and medications; provision of medical information about pharmaceutical products; medicalmedicinal and pharmaceutical consultancy; Medical and pharmaceutical consultationadvisory services in the field of pharmaceutical products; analysis and provision of clinical data of patients for diagnostic or treatment purpose; provision of information on pharmaceuticals and medical services through computer databases; medical testing for the collection of medical informationanalysis and provision of medical information for diagnostic or treatment purposes; medical testing; Consultancy in the field of the medical diagnosis of cardiovascular disordersgenitourinary disordersgynecological diseases and obstetric diseasescancer and its metastasiseye disordersneurologic disorderspsychiatric disordersendocrine and metabolic disordersallergic disordersgastrointestinal disordersimmune diseases and autoimmune diseasesrespiratory diseasesmusculoskeletal and connective tissue disordersinfectious diseasesdermatologic disordershematological disorderinflammatory diseasesearnosedental and throat disordershepatic and biliary disordersAlzheimer's diseasediabetes and its complications via the Internet; online medical counseling services; Remote monitoring of medical data for medical diagnosis and treatmentremote monitoring of patient health status for medical conditions; remote monitoring of medical data for medical diagnosis and treatment; providing medical information; physical examination services; Providing medical informationinformation about pharmaceuticalsmedical services and health; Medical consultancy relating to medical servicespharmaceuticalshealth and dispensing of medications; Medical consultancyadvisory and provision of information relating to dietingnutritional intake and health care; Medical consultancyadvisory and provision of information relating to health care; managed health care services; Providing health informationprovision of records of personal health information data such as weightbody fatbody temperaturenumber of stepssleeping hours and blood pressure; Medical nutritional consultancy and advisory for preventing and decreasing obesity; provision of information about nutritional consultancy and advisory for preventing and decreasing obesity; dietary and nutritional guidance; nursing care; rental of medical apparatus and instruments
Publicações
Histórico de despachos e eventos da marca no USPTO.
28 publicações encontradas
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/05/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
12/05/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
24/03/2026
PUBO
PUBLISHED FOR OPPOSITION
24/03/2026
GPNX
NOTIFICATION PROCESSED BY IB
19/03/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
18/03/2026
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/03/2026
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
03/03/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
26/02/2026
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
14/11/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
14/11/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
14/11/2025
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
11/11/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/11/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/11/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
11/11/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
11/11/2025
RFNT
REFUSAL PROCESSED BY IB
10/10/2025
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
24/09/2025
RFRR
REFUSAL PROCESSED BY MPU
24/09/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
13/08/2025
CNRT
NON-FINAL ACTION WRITTEN
12/08/2025
DOCK
ASSIGNED TO EXAMINER
25/06/2025
MAFR
APPLICATION FILING RECEIPT MAILED
24/06/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
24/06/2025
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
24/06/2025
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
19/06/2025
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace STANDING TOGETHER WITH PATIENTS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.